RNS Number:0816K
ReGen Therapeutics PLC
15 April 2003


ReGen Therapeutics Plc

15 April 2003


The following replaces the substantial shareholding announcement issued on the
14th April 2003 reference 0254K at 16.34hrs. The number of shares acquired by
Hoodless Brennan on the 10 April should read 27,333,333 shares and not
32,793,333. This represented 19.4% and not 23.7% of the issued share capital of
ReGen Therapeutics. The disposal figures have also been adjusted and the net
effect, ie the shareholding of below 3% remains the same.


Immediate Release


                             ReGen Therapeutics Plc

                            SUBSTANTIAL SHAREHOLDING


London, UK - 15 April, 2003: ReGen Therapeutics Plc (the "Company") announces it
has been notified by Hoodless Brennan & Partners Plc ("Hoodless") of amendments
to its notification to its holding of ordinary shares of the Company. On 10
April 2003 Hoodless acquired 27,333,333 ordinary shares representing 19.4% of
the issued share capital of the Company.

Further, the Company received notification from Hoodless on 15 April 2003 that,
following a disposal by it of 7,121,666 ordinary shares of the Company on 10
April 2003, and a further disposal of 20,055,500 ordinary shares of the Company
on 11 April 2003, its shareholding is now less than 3% of the issued share
capital of the Company.


For further information, please contact:


Andrew Marshall                                               Tel. 020 7489 2033
Marshall Robinson Roe


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
HOLGGGMDNKGGFZM